Cancer research has significantly advanced in understanding prevention and epidemiology, offering hope for reducing its global burden. Prevention focuses on mitigating risk factors like tobacco use, poor diet, and sedentary lifestyles. Public health initiatives, including vaccinations for HPV and hepatitis B, have proven effective in lowering incidences of cervical and liver cancers.
Epidemiology provides valuable insights by studying cancer patterns, causes, and distribution. It helps identify high-risk populations and environmental triggers, paving the way for targeted interventions. Advances in genetic profiling further enable the early detection of hereditary cancers. Combining these strategies enhances cancer prevention, fostering healthier communities and improving global health outcomes.
Title : The role of artificial intelligence (AI) in oncology
Marika Crohns, Impactful Innovations Management Consultants LLC, United Arab Emirates
Title : Principles of oral rehabilitation in H&N cancer patients
Pietro Salvatori, Independent H&N Surgeon, Italy
Title : Molecular-genetic study of low-grade and high-grade “basal-like” (triple-negative) breast carcinomas
Farid Moinfar, Ordensklinikum Linz Barmherzige Schwestern, Austria
Title : The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment
Bene Ekine-Afolabi, University of East London, United Kingdom
Title : Altered expression of endoplasmic reticulum stress response genes and circular RNAs in oral squamous cell carcinoma tumorigenesis
Vandana Tiwari, Dr. Ram Manohar Lohia Institute of Medical Sciences, India
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom